Invivo Partners
Invivo Partners, which invests under the Invivo Ventures brand and is regulated as Invivo Partners, SGEIC, S.A., is a Barcelona venture capital firm founded in 2012 by Luis Pareras and Albert Ferrer. It backs early-stage European life-sciences companies focused on advanced therapies, synthetic biology and AI-driven drug development, having raised the 60 million euro Invivo Ventures fund and the larger Invivo Ventures III, and is now expanding into deeptech and AI through its new InvivoAI fund; notable exits include Sanifit, Versantis and EsoBiotec.
Key facts
Recent exits
Coverage notes
3 funds tracked, 15 portfolio companies (12 active · 3 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Invivo Partners has raised, with its portfolio companies. Hand-checked from public filings.
Invivo Ventures IIILife Sciences VC2024 · 2yr2 active
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2025 | ||
| Biotech | 2025 |
Invivo VenturesLife Sciences VCHarvesting2019 · 7yr€60M8 active · 2 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2020 | ||
| Biotech | 2021 | ||
| Biotech | 2020 | ||
| Biotech | 2021 | ||
| Biotech | 2023 | ||
| Biotech | 2020 | ||
| Biotech | 2020 | ||
| Biotech | 2020 |
HealthequityLife Sciences VCHarvesting2012 · 14yr2 active · 1 realized
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2015 | ||
| Biotech | 2016 |
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | 2014 | 2021 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Invivo Partners.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in